A major mechanism involved in the regulation of tumour-promoting genes by tumour cells is the loss of E-cadherin mediated cell-cell adhesion. , E-cadherin is a transmembrane glycoprotein found in adherens junctions implicated in the maintenance of a polarized and 19 20 cohesive epithelium. In normal conditions, the intracellular domain of the E-cadherin is linked to the actin cytoskeleton cytoplasmic via linkers: the catenins ( -, -and -catenin). In pathological processes including cancer progression, -catenin can accumulate in the β including matrix metalloproteases, cytoskeletal proteins or angiogenic cytokines and chemokines (IL-8, MMP-7, MMP-14, CD44, cyclin D1, c-myc, claudin-1, vimentin, MMP26, VEGF ), some of them having important implications in cancer progression. 
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These independent data from the literature therefore suggest that a reorganisation of E-cadherin/ -catenin and an overexpression of supplemented with 10 FCS, 2 mM of L-glutamine and 100 Ul/ml of penicillin and streptomycin (Life Technologies).
%
RT-PCR analysis
Total RNA was extracted using the High Pure RNA isolation kit (Roche Diagnostics, Mannheim, Germany). Ten nanograms of RNA was then reverse transcribed into cDNA and amplified using the GeneAmp Thermostable rTth enzyme (Perkin Elmer Life Sciences, Boston, MA). The following reverse (R) and forward (F) primers were used: MCP-1R 5 -AATGGTCTTGAAGATCAC-AGCTTC-3 , 
Immunofluorescence
Confluent cell monolayers on glass coverslips were fixed in 2.5 paraformaldehyde in PBS for 30 min and then permeabilized with % 0,2 Triton X-100 for 15 min at room temperature. The coverslips were then saturated for 30 min with 3 bovine serum albumin in PBS. 3 12 1,399 bp upstream of the transcription initiation start. We also constructed a reporter vector containing a mutated -catenin/TCF binding β site (5 -CTTTGGC-3 ) using the Quick Change site directed mutagenesis kit (Stratagene, LaJolla, CA) according to the manufacturer s
instructions. The mutation was verified by sequencing. Such a two nucleotide substitution in the -catenin/TCF binding site has previously 
Luciferase reporter assays
Transient transfection experiments were performed using Fugene-6 transfection reagent (Roche Diagnostics) on 5 10 MCF7, BT549 transfection, the cells were extensively washed with PBS and incubated for 48 hr in culture medium before they were harvested for RT-PCR, Western blotting or Elisa analyses.
Results

MCP-1 is expressed by invasive, E-cadherin-negative breast cancer cell lines
In order to establish a potential relationship between a reorganization of E-cadherin/ -catenin complexes and MCP-1 expression, we ). This selective expression of MCP-1 by Fig. 1a invasive, E-cadherin-negative breast cancer cell lines was confirmed at the protein level by ELISA (
). Looking at -catenin Fig. 1b expression 
Discussion
In our study, we first demonstrated that MCP-1 is selectively expressed in breast tumour cell lines known to display high in vitro invasive properties and reorganized E-cadherin/ -catenin complexes. Even though the correlation between a reorganisation of E-cadherin/ β -catenin complexes and MCP-1 expression has never been reported before, the large amount of data from the literature, associating β E-cadherin/ -catenin complexes reorganization and the expression of an invasive phenotype , , strengthen our findings. 
